Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Clinical Epigenetics|December 20, 2025
Novel DNA methylation biomarkers in urine for non-invasive diagnosis of bladder urothelial carcinomaCong Shi, Jianglei Xu, Qinyu Chen, et al.
International Urology and Nephrology|September 17, 2014
Docetaxel with or without zoledronic acid for castration-resistant prostate cancerYue Pan, Haiyong Jin, Wei Chen, et al.
Frontiers in Oncology|July 10, 2023
Genomic profiles of renal cell carcinoma in a small Chinese cohortSheng Tai, Dan-Dan Xu, Zhixian Yu, et al.
Journal of Cancer Research and Clinical Oncology|March 8, 2025
Identification of LIMK1 as a biomarker in clear cell renal cell carcinoma: from data mining to validationYifei Li, Congcong Fan, Feng Jiang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 16, 2015
[Association of polymorphism in the promoter region of PCA3 gene with risk of prosate cancer]Wu Zhou, Zhihua Tao, Zhongyong Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 13, 2023
Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11Zhichao Lang, Suhui Yu, Yuhang Hu, et al.
Chemico-Biological Interactions|July 11, 2026
MT2A facilitates the malignant progression of clear cell renal cell carcinoma by activating the TFAP2A/YAP axis via histone lactylationWeiping Huang, Feng Jiang, Weizhi Zhang, et al.
Pageof 7